Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 23, 2024 08:01 ET | Source: Corxel Pharmaceuticals

CORXEL Acquires Worldwide (excluding Greater China) Rights to an Oral Small Molecule GLP-1 RA for the Treatment of Obesity and Diabetes

CORXEL expands its cardiometabolic pipeline into obesity and diabetes.